{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T15:52:16Z","timestamp":1782057136695,"version":"3.54.5"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>PET\/CT targeting fibroblast activation protein \u03b1 (FAP) in cancer-associated fibroblasts shows promise in theranostics. Here, we report the case of a 31-year-old woman with hormone receptor\u2013positive\/human epidermal growth factor receptor 2\u2013negative breast cancer who presented with rising CA15-3 for further diagnostic workup. Whereas [<jats:sup>18<\/jats:sup>F]FDG PET\/CT was unremarkable, novel [<jats:sup>68<\/jats:sup>Ga]RTX-1363 PET\/CT revealed intense tracer accumulation in thoracoabdominal lymph nodes and both ovaries. Follow-up imaging confirmed tumor progression, and diagnostic laparoscopy verified metastatic disease in the ovaries with high FAP expression in the tumor stroma. This case underscores the superior sensitivity of [<jats:sup>68<\/jats:sup>Ga]RTX-1363 PET\/CT over [<jats:sup>18<\/jats:sup>F]FDG PET\/CT, enhancing breast cancer diagnostic and therapeutic strategies.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005689","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T23:00:36Z","timestamp":1737673236000},"page":"444-445","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Intense FAP Expression of Ovarian Metastatic Breast Cancer Detected by [68Ga]RTX-1363 PET\/CT"],"prefix":"10.1097","volume":"50","author":[{"given":"Lisa","family":"Glantschnig","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nic G.","family":"Reitsam","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kircher, MD","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Segmiller","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Lapa","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Dierks","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"bib1-20250403","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"bib2-20250403","first-page":"241736","article-title":"Preclinical characterization of [Cu-64] RTX-1363S: a highly selective and high-affinity FAP inhibitor for PET imaging","volume":"65","author":"Hillier","year":"2024","journal-title":"J Nucl Med"},{"key":"bib3-20250403","first-page":"241693","article-title":"First-in-human study of a high affinity FAP imaging agent [Cu-64] LNTH-1363S","volume":"65","author":"Hesterman","year":"2024","journal-title":"J Nucl Med"},{"key":"bib4-20250403","article-title":"Breast cancer","author":"Kasper","year":"2016","journal-title":"Harrison\u2019s Manual of Medicine"},{"key":"bib5-20250403","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1053\/j.seminoncol.2014.12.020","article-title":"Synchronous primary carcinoma of breast and ovary versus ovarian metastases","volume":"42","author":"Yadav","year":"2015","journal-title":"Semin Oncol"},{"key":"bib6-20250403","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004347-198706000-00008","article-title":"Secondary ovarian carcinoma: a clinical and pathological evaluation","volume":"6","author":"Demopoulos","year":"1987","journal-title":"Int J Gynecol Pathol"},{"issue":"3B","key":"bib7-20250403","first-page":"2339","article-title":"Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results","volume":"26","author":"Tserkezoglou","year":"2006","journal-title":"Anticancer Res"},{"key":"bib8-20250403","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cncr.24807","article-title":"Ovarian metastases from breast cancer","volume":"116","author":"Bigorie","year":"2010","journal-title":"Cancer"},{"key":"bib9-20250403","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.humpath.2013.06.016","article-title":"Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer","volume":"44","author":"Tchou","year":"2013","journal-title":"Hum Pathol"},{"key":"bib10-20250403","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12149-021-01616-5","article-title":"68Ga-FAPI-04 PET\/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET\/CT","volume":"35","author":"K\u00f6mek","year":"2021","journal-title":"Ann Nucl Med"},{"key":"bib11-20250403","first-page":"2372","article-title":"Head to head comparison of 68Ga-FAPI-46 PET\/CT and 18-FDG PET\/CT in breast carcinoma staging: a clinical trial update from Azerbaijan","volume":"63","author":"Novruzov","year":"2022","journal-title":"J Nucl Med"},{"key":"bib12-20250403","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/RLU.0000000000005537","article-title":"Predicting malignancy in adnexal tumors with FAPI PET\/CT and FDG PET\/CT: a case report on a borderline ovarian tumor","volume":"50","author":"Umachanger","year":"2024","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T01:31:28Z","timestamp":1743730288000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005689","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"2024-08-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}